Clinical Trial Update: A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain [Phase 1]

View source ↗

Summary

A two-part Phase 1 study evaluating the safety and efficacy of LAT8881 in patients with lumbar radiculopathy; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Radiculopathy

Drugs mentioned

• LAT8881

Snippet

Sponsor: Lateral Pharma Pty Ltd | Conditions: Radiculopathy Lumbar | Phase 1 | Status: COMPLETED | Results posted: 2024-11-27